(The North American Menopause Society (NAMS)) Advances are regularly being made in cancer genetics. But, if patients aren't screened and diagnosed early enough, the advances can't save lives. A presentation at The North American Menopause Society (NAMS) Annual Meeting in San Diego, Oct. 3-6, will review the various genetic testing options for breast cancer, as well as profile those who should be tested.
from EurekAlert! - Social and Behavioral Science https://ift.tt/2O0YU9f
No comments:
Post a Comment